Female Reproductive System Carcinoma — Trials

Female Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,481 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 458
Recruiting: 230
Ph III recruiting: 25
Growth YoY: +35.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 201–218 of 218 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06420973	RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression	recruiting	Phase 2	54	Peking University Cancer Hospital & InstituteOTHER	1	May 20, 2024	clinicaltrials
NCT06413992	Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer	recruiting	Phase 2	117	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	1	May 14, 2024